Phase 3 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with non-small cell lung cancer (a specific type of lung cancer), confirmed by a lab test on a tissue or cell sample.
- Your lung cancer is either advanced (Stage IIIB or IIIC) and cannot be treated with surgery or chemotherapy/radiation to try to cure it, or it has spread to other parts of the body (Stage IV).
- You are able to provide either a stored tumor tissue sample taken within the last 5 years, or a new tissue sample from a tumor that has not been previously treated with radiation, for laboratory testing.
- If you had side effects from previous cancer treatments, those side effects have mostly or fully gone away.
- If you have HIV, it is well managed with medication.
- If you have Hepatitis B, you have been on treatment for it for at least 4 weeks and the virus is not detectable in your blood.
- If you have a history of Hepatitis C, the virus is not currently detectable in your blood.
Who may not be able to join:
- You have been diagnosed with small cell lung cancer, or your tumor contains any small cell elements.
- You have active inflammatory bowel disease (such as Crohn's disease or ulcerative colitis) that requires immune-suppressing medication, or you have a clear history of inflammatory bowel disease.
- You have a known history of, or currently have, a nervous system condition caused by your cancer (known as a paraneoplastic syndrome) (confirm with trial site).
- You currently have an active infection that requires treatment with medications taken throughout your body (such as antibiotics or antivirals).
- You have serious, uncontrolled heart or blood vessel disease, or uncontrolled brain or stroke-related conditions.
- You have certain eye conditions, including eye pressure above a certain level, glaucoma, specific retinal diseases, or other listed eye problems.
- You have already received systemic (whole-body) cancer treatment for your advanced or metastatic lung cancer.
- You have received high-dose radiation to your lungs within the past 6 months.
- You have received any radiation therapy within the past 2 weeks, or have not fully recovered from its side effects.
- You have active cancer that has spread to your brain or the lining around your brain and spinal cord.
- You have another cancer that is growing or has needed active treatment within the past 3 years.
- You have an autoimmune disease (where your immune system attacks your own body) that has needed systemic treatment within the past 2 years.
- You have a history of, or currently have, lung inflammation or scarring (pneumonitis or interstitial lung disease) that required or requires steroid treatment.
- You have HIV and also have a history of Kaposi's sarcoma or Multicentric Castleman's Disease.
- You have had an organ or tissue transplant from another person.
- You have not fully recovered from a recent major surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, Merck Sharp & Dohme LLC
Phone: 1-888-577-8839
Australian sites
+61285140140
+610743256110
+61397847777
+61862799466
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
4 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Progression-Free Survival (PFS); Overall Survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.